Huber K - Search Results

1

Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model.

Farhan S, Hemetsberger R, Matiasek J, Strehblow C, Pavo N, Khorsand A, Petneházy O, Petrási Z, Kaider A, Glogar D, Huber K, Gyöngyösi M. Farhan S, et al. Among authors: huber k. Atherosclerosis. 2009 Jan;202(1):144-51. doi: 10.1016/j.atherosclerosis.2008.04.039. Epub 2008 Apr 29. Atherosclerosis. 2009. PMID: 18514201

2

Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support.

Schreiber W, Herkner H, Koreny M, Bur A, Hirschl MM, Glogar D, Huber K, Laggner AN. Schreiber W, et al. Among authors: huber k. Resuscitation. 2002 Dec;55(3):269-76. doi: 10.1016/s0300-9572(02)00266-6. Resuscitation. 2002. PMID: 12458064

3

Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.

Gyöngyösi M, Glogar D, Weidinger F, Domanovits H, Laggner A, Wojta J, Zorn G, Iordanova N, Huber K. Gyöngyösi M, et al. Among authors: huber k. Am Heart J. 2004 Jan;147(1):158-64. doi: 10.1016/j.ahj.2003.07.015. Am Heart J. 2004. PMID: 14691435

4

Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.

Gyöngyösi M, Domanovits H, Benzer W, Haugk M, Heinisch B, Sodeck G, Hödl R, Gaul G, Bonner G, Wojta J, Laggner A, Glogar D, Huber K; ReoPro-BRIDGING Study Group. Gyöngyösi M, et al. Among authors: huber k. Eur Heart J. 2004 Dec;25(23):2125-33. doi: 10.1016/j.ehj.2004.09.018. Eur Heart J. 2004. PMID: 15571828 Clinical Trial.

5

Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.

Jarai R, Iordanova N, Jarai R, Raffetseder A, Woloszczuk W, Gyöngyösi M, Geyer G, Wojta J, Huber K. Jarai R, et al. Among authors: huber k. Eur Heart J. 2005 Feb;26(3):250-6. doi: 10.1093/eurheartj/ehi038. Epub 2004 Dec 20. Eur Heart J. 2005. PMID: 15618049

6

New cut-off values of cardiac markers for risk stratification of angina pectoris.

Jordanova N, Gyöngyösi M, Khorsand A, Falkensammer C, Zorn G, Wojta J, Anvari A, Huber K. Jordanova N, et al. Among authors: huber k. Int J Cardiol. 2005 Mar 30;99(3):429-35. doi: 10.1016/j.ijcard.2004.03.003. Int J Cardiol. 2005. PMID: 15771924

7

Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant.

Gulesserian T, Wenzel C, Endler G, Sunder-Plassmann R, Marsik C, Mannhalter C, Iordanova N, Gyöngyösi M, Wojta J, Mustafa S, Wagner O, Huber K. Gulesserian T, et al. Among authors: huber k. Clin Chem. 2005 Sep;51(9):1661-5. doi: 10.1373/clinchem.2005.051581. Epub 2005 Jul 14. Clin Chem. 2005. PMID: 16020495

8

Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease.

Steiner S, Niessner A, Ziegler S, Richter B, Seidinger D, Pleiner J, Penka M, Wolzt M, Huber K, Wojta J, Minar E, Kopp CW. Steiner S, et al. Among authors: huber k. Atherosclerosis. 2005 Aug;181(2):305-10. doi: 10.1016/j.atherosclerosis.2005.01.006. Epub 2005 Feb 12. Atherosclerosis. 2005. PMID: 16039284

9

Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque stabilization?

Niessner A, Richter B, Penka M, Steiner S, Strasser B, Ziegler S, Heeb-Elze E, Zorn G, Leitner-Heinschink A, Niessner C, Wojta J, Huber K. Niessner A, et al. Among authors: huber k. Atherosclerosis. 2006 May;186(1):160-5. doi: 10.1016/j.atherosclerosis.2005.06.047. Epub 2005 Aug 9. Atherosclerosis. 2006. PMID: 16084517 Clinical Trial.

10

Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo.

Niessner A, Steiner S, Speidl WS, Pleiner J, Seidinger D, Maurer G, Goronzy JJ, Weyand CM, Kopp CW, Huber K, Wolzt M, Wojta J. Niessner A, et al. Among authors: huber k. Atherosclerosis. 2006 Dec;189(2):408-13. doi: 10.1016/j.atherosclerosis.2005.12.022. Epub 2006 Jan 26. Atherosclerosis. 2006. PMID: 16443229 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,097 results

Search Page

Filters